고분자량 헤파린 조성물 및 호산구 매개 염증 질환 진단, 치료 및 모니터링 방법
고분자량 헤파린을 포함하는 조성물이 본원에 개시된다. 조성물은 약 20kDa 내지 약 40kDa의 평균 분자량을 가지며 적어도 50%의 순도를 갖는 고분자량 헤파린의 유효량, 및 약학적으로 허용 가능한 부형제를 포함한다. 대상체에서 호산구 관련 염증을 치료하는 방법이 또한 본원에 개시된다. Disclosed herein are compositions comprising high molecular weight heparin. The compositions comprise an effective amount of high molecul...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GLEICH GERALD J ECKERT DEBRA SAFFARI HEDIEH CONDIE RUSSELL MORRIS LEIFERMAN KRISTIN M PETERSON KATHRYN A |
| description | 고분자량 헤파린을 포함하는 조성물이 본원에 개시된다. 조성물은 약 20kDa 내지 약 40kDa의 평균 분자량을 가지며 적어도 50%의 순도를 갖는 고분자량 헤파린의 유효량, 및 약학적으로 허용 가능한 부형제를 포함한다. 대상체에서 호산구 관련 염증을 치료하는 방법이 또한 본원에 개시된다.
Disclosed herein are compositions comprising high molecular weight heparin. The compositions comprise an effective amount of high molecular weight heparin having an average molecular weight from about 20 kDa to about 40 kDa and having a purity of at least 50%, and a pharmaceutically acceptable excipient. Disclosed herein are also methods of treating eosinophil-related inflammation in a subject. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20220143016A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20220143016A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20220143016A3</originalsourceid><addsrcrecordid>eNrjZMh6tXnB620tb-ZNeD2_U-Ht9CVve3peL9ug8GbhhjctG1-v2aPwekO_wtsZO940bXi1dY3C6-VLXm2Yo_Bm-p43y-YqvFne8XbmDCDV8rp7hY7Cm50zXi_uAet4vWrF6-6Oty0bXi9vBAqsfL1pKg8Da1piTnEqL5TmZlB2cw1x9tBNLciPTy0uSExOzUstifcOMjIwMjIwNDE2MDRzNCZOFQBTAl7v</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>고분자량 헤파린 조성물 및 호산구 매개 염증 질환 진단, 치료 및 모니터링 방법</title><source>esp@cenet</source><creator>GLEICH GERALD J ; ECKERT DEBRA ; SAFFARI HEDIEH ; CONDIE RUSSELL MORRIS ; LEIFERMAN KRISTIN M ; PETERSON KATHRYN A</creator><creatorcontrib>GLEICH GERALD J ; ECKERT DEBRA ; SAFFARI HEDIEH ; CONDIE RUSSELL MORRIS ; LEIFERMAN KRISTIN M ; PETERSON KATHRYN A</creatorcontrib><description>고분자량 헤파린을 포함하는 조성물이 본원에 개시된다. 조성물은 약 20kDa 내지 약 40kDa의 평균 분자량을 가지며 적어도 50%의 순도를 갖는 고분자량 헤파린의 유효량, 및 약학적으로 허용 가능한 부형제를 포함한다. 대상체에서 호산구 관련 염증을 치료하는 방법이 또한 본원에 개시된다.
Disclosed herein are compositions comprising high molecular weight heparin. The compositions comprise an effective amount of high molecular weight heparin having an average molecular weight from about 20 kDa to about 40 kDa and having a purity of at least 50%, and a pharmaceutically acceptable excipient. Disclosed herein are also methods of treating eosinophil-related inflammation in a subject.</description><language>kor</language><subject>HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; TESTING</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221024&DB=EPODOC&CC=KR&NR=20220143016A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221024&DB=EPODOC&CC=KR&NR=20220143016A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GLEICH GERALD J</creatorcontrib><creatorcontrib>ECKERT DEBRA</creatorcontrib><creatorcontrib>SAFFARI HEDIEH</creatorcontrib><creatorcontrib>CONDIE RUSSELL MORRIS</creatorcontrib><creatorcontrib>LEIFERMAN KRISTIN M</creatorcontrib><creatorcontrib>PETERSON KATHRYN A</creatorcontrib><title>고분자량 헤파린 조성물 및 호산구 매개 염증 질환 진단, 치료 및 모니터링 방법</title><description>고분자량 헤파린을 포함하는 조성물이 본원에 개시된다. 조성물은 약 20kDa 내지 약 40kDa의 평균 분자량을 가지며 적어도 50%의 순도를 갖는 고분자량 헤파린의 유효량, 및 약학적으로 허용 가능한 부형제를 포함한다. 대상체에서 호산구 관련 염증을 치료하는 방법이 또한 본원에 개시된다.
Disclosed herein are compositions comprising high molecular weight heparin. The compositions comprise an effective amount of high molecular weight heparin having an average molecular weight from about 20 kDa to about 40 kDa and having a purity of at least 50%, and a pharmaceutically acceptable excipient. Disclosed herein are also methods of treating eosinophil-related inflammation in a subject.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZMh6tXnB620tb-ZNeD2_U-Ht9CVve3peL9ug8GbhhjctG1-v2aPwekO_wtsZO940bXi1dY3C6-VLXm2Yo_Bm-p43y-YqvFne8XbmDCDV8rp7hY7Cm50zXi_uAet4vWrF6-6Oty0bXi9vBAqsfL1pKg8Da1piTnEqL5TmZlB2cw1x9tBNLciPTy0uSExOzUstifcOMjIwMjIwNDE2MDRzNCZOFQBTAl7v</recordid><startdate>20221024</startdate><enddate>20221024</enddate><creator>GLEICH GERALD J</creator><creator>ECKERT DEBRA</creator><creator>SAFFARI HEDIEH</creator><creator>CONDIE RUSSELL MORRIS</creator><creator>LEIFERMAN KRISTIN M</creator><creator>PETERSON KATHRYN A</creator><scope>EVB</scope></search><sort><creationdate>20221024</creationdate><title>고분자량 헤파린 조성물 및 호산구 매개 염증 질환 진단, 치료 및 모니터링 방법</title><author>GLEICH GERALD J ; ECKERT DEBRA ; SAFFARI HEDIEH ; CONDIE RUSSELL MORRIS ; LEIFERMAN KRISTIN M ; PETERSON KATHRYN A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20220143016A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>kor</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>GLEICH GERALD J</creatorcontrib><creatorcontrib>ECKERT DEBRA</creatorcontrib><creatorcontrib>SAFFARI HEDIEH</creatorcontrib><creatorcontrib>CONDIE RUSSELL MORRIS</creatorcontrib><creatorcontrib>LEIFERMAN KRISTIN M</creatorcontrib><creatorcontrib>PETERSON KATHRYN A</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GLEICH GERALD J</au><au>ECKERT DEBRA</au><au>SAFFARI HEDIEH</au><au>CONDIE RUSSELL MORRIS</au><au>LEIFERMAN KRISTIN M</au><au>PETERSON KATHRYN A</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>고분자량 헤파린 조성물 및 호산구 매개 염증 질환 진단, 치료 및 모니터링 방법</title><date>2022-10-24</date><risdate>2022</risdate><abstract>고분자량 헤파린을 포함하는 조성물이 본원에 개시된다. 조성물은 약 20kDa 내지 약 40kDa의 평균 분자량을 가지며 적어도 50%의 순도를 갖는 고분자량 헤파린의 유효량, 및 약학적으로 허용 가능한 부형제를 포함한다. 대상체에서 호산구 관련 염증을 치료하는 방법이 또한 본원에 개시된다.
Disclosed herein are compositions comprising high molecular weight heparin. The compositions comprise an effective amount of high molecular weight heparin having an average molecular weight from about 20 kDa to about 40 kDa and having a purity of at least 50%, and a pharmaceutically acceptable excipient. Disclosed herein are also methods of treating eosinophil-related inflammation in a subject.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | kor |
| recordid | cdi_epo_espacenet_KR20220143016A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING |
| title | 고분자량 헤파린 조성물 및 호산구 매개 염증 질환 진단, 치료 및 모니터링 방법 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A33%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GLEICH%20GERALD%20J&rft.date=2022-10-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20220143016A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |